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Virus infections can result in a variety of cellular injuries, and these often involve the permeabilization of
host membranes by viral proteins of the viroporin family. Prototypical viroporin 2B is responsible for the
alterations in host cell membrane permeability that take place in enterovirus-infected cells. 2B protein can be
localized at the endoplasmic reticulum (ER) and the Golgi complex, inducing membrane remodeling and the
blockade of glycoprotein trafficking. These findings suggest that 2B has the potential to integrate into the ER
membrane, but specific information regarding its biogenesis and mechanism of membrane insertion is lacking.
Here, we report experimental results of in vitro translation-glycosylation compatible with the translocon-
mediated insertion of the 2B product into the ER membrane as a double-spanning integral membrane protein
with an N-/C-terminal cytoplasmic orientation. A similar topology was found when 2B was synthesized in
cultured cells. In addition, the in vitro translation of several truncated versions of the 2B protein suggests that
the two hydrophobic regions cooperate to insert into the ER-derived microsomal membranes.
Virus infections can lead to a variety of cellular injuries, and
usually these involve the restructuring of host membrane sys-
tems. Viroporins are a group of small virally encoded proteins
that interact with cellular membranes to modify permeability
and promote the release of viral particles. A typical feature
exhibited by viroporins is the presence of at least one mem-
brane-spanning helix anchoring the protein into membranes.
After membrane insertion, their oligomerization creates hy-
drophilic channels or pores (22).
Poliovirus is the enterovirus prototype member of the Picor-
naviridae family. This small, nonenveloped, icosahedral virus
possesses a single-stranded 7.5-kb positive-sense RNA genome
that encodes a single polyprotein. Polyprotein processing by
virus-encoded proteases yields the structural P1 region pro-
teins that encapsidate viral RNA and the nonstructural P2 and
P3 region proteins involved in the replication of the viral RNA
and membrane permeabilization (2). Nonstructural 2B protein
is one of the products generated on processing the P2 region
(62). Viroporin 2B has been identified as one of the viral
proteins responsible for the alterations in host cell membrane
permeability that take place in enterovirus-infected cells. Dif-
ferent 2B proteins expressed in cells have been localized at the
endoplasmic reticulum (ER), Golgi complex, and, to a lesser
extent, to the plasma and mitochondrial membranes (18, 31,
49, 58). Biochemical and structural data indicate that viro-
porins form homo-oligomers that create pores in the ER and
Golgi complex membranes (1, 16, 17, 30, 59). However, exper-
imental data dealing with the mechanism of the membrane
integration of the 2B product are lacking to date.
The poliovirus 2B viroporin protein is hydrophobic overall
and rather small (97 amino acids). Hydrophobicity within the
viroporin 2B sequence seems to cluster in two main regions
(Fig. 1), one predicted to form a cationic amphipathic -helix
located between residues 35 and 55 (HR1) and a second, more
hydrophobic, -helix located between residues 61 and 81
(HR2), as previously suggested (1). Mutations in the amphi-
pathic -helix or the second hydrophobic region were shown to
interfere with the ability of 2B to increase membrane perme-
ability to promote virus release (3, 8, 58) and with viral RNA
replication (57), indicating that the soundness of these regions
is essential for viral infection. The amphipathic -helices of
several 2B proteins contain three lysine residues at similar
positions, and the presence of an aspartic acid residue also is
common in the hydrophobic HR2 region (15), suggesting an
-helical hairpin structure.
Two views of the insertion process of -helical hairpins into
the membrane bilayer can be envisioned. One view postulates
-helical hairpin insertion to be a spontaneous process that
does not require specific machinery (9, 19). The other supposes
a role for the translocon, which is responsible for facilitating
the translocation of secreted proteins across the membrane
and insertion of membrane proteins into the lipid bilayer (27,
46), allowing en bloc -helical hairpin insertion from a pro-
teinaceous environment into the lipid bilayer (51).
In the present study, we find that viroporin 2B is an integral
membrane protein that can be inserted into the ER membrane
through the translocon. The in vitro translation of model inte-
gral membrane protein constructs in the presence of micro-
somal membranes initially suggested that when expressed sep-
arately, only the amphipathic helix (HR1) can span the
membrane. However, the in vitro translation of truncated ver-
sions of the 2B protein carrying appropriate C-terminal re-
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porter glycosylation tags further demonstrated that (i) the N-
terminal hydrophobic domain may be stably inserted into the
ER-derived microsomal membranes through the translocon,
provided that an Ncyt/Clum topology is preserved (Ncy, N-ter-
minal end of the transmembrane [TM] segment is oriented
toward the cytosol; Clum, C-terminal end of the TM segment is
oriented toward the lumen); and (ii) within the complete 2B
protein the two hydrophobic regions cooperate to insert into
the ER membrane as a helical hairpin with an N-/C-terminal
cytoplasmic orientation. In addition, a similar topology was
adopted by viroporin 2B expressed in cultured cells under
conditions leading to plasma membrane permeabilization.
MATERIALS AND METHODS
Enzymes and chemicals. All enzymes (unless indicated otherwise) as well as
plasmid pGEM1, the RiboMAX SP6 RNA polymerase system, and rabbit re-
ticulocyte lysate (a cell-free translation system) were purchased from Promega
(Madison, WI). The ER rough microsomes from dog pancreas were purchased
from tRNA Probes (College Station, TX). To ensure consistent performance
with minimal translational inhibition and background noise, microsomes have
been isolated free from contaminating membrane fractions and stripped of
endogenous membrane-bound ribosomes and mRNA. The [35S]Met/Cys and
14C-methylated markers were purchased from GE Healthcare. The restriction
enzymes and endoglycosidase H (EndoH) were purchased from Roche Molec-
ular Biochemicals. The DNA plasmid, RNA clean-up, and PCR purification kits
were from Qiagen (Hilden, Germany). The PCR QuikChange mutagenesis kit
was from Stratagene (La Jolla, CA). All oligonucleotides were purchased from
Thermo (Ulm, Germany).
Computer-assisted analysis of viroporin 2B sequence. The prediction of TM
helices was done using up to 10 of the most common methods available on the
Internet: DAS (14) (http://www.sbc.su.se/miklos/DAS), PHDhtm (47) (http:
//www.predictprotein.org/), MEMSAT3 (28) (http://bioinf.cs.ucl.ac.uk/psipred/),
MEMSAT-SVM (43) (http://bioinf.cs.ucl.ac.uk/psipred/), SOSUI (26) (http://bp
.nuap.nagoya-u.ac.jp/sosui/), TMHMM (29) (http://www.cbs.dtu.dk/services
/TMHMM), TMPred (http://www.ch.embnet.org/software/TMPRED_form
.html), G Prediction Server (24, 25) (http://www.cbr.su.se/DGpred/),
SPOCTOPUS (60) (http://octopus.cbr.su.se/), and TopPRED (12) (http:
//www.sbc.su.se/erikw/toppred2/).
DNA manipulations. Plasmids encoding full-length 2B sequence (without a
stop codon) were constructed by subcloning poliovirus serotype 1 (PV1) Ma-
honey strain 2B-encoding DNA (kindly provided by E. Wimmer, Stony Brook
University) (56) into pGEM1 vector between the NcoI and NdeI restriction sites.
This construct contained the P2 domain of the Escherichia coli leader peptidase
(Lep) fused in frame at the C terminus, as described previously (41). Alterna-
tively, we prepared templates for the in vitro transcription of the truncated 2B
mRNA with a 3 glycosylation tag. The truncated viroporin 2B sequence was
prepared by the PCR amplification of a fragment of the pGEM1 plasmid. The 5
primer was the same for all PCRs and had the sequence 5-TTCGTCCAACC
AAACCGACTC-3. This primer was situated 210 bases upstream of the 2B
translational start codon; thus, all amplified fragments contained the SP6 tran-
scriptional promoter from pGEM1. The 3 primers were designed to have ap-
proximately the same annealing temperature as the 5 primer. They contained an
optimized glycosylation tag followed by tandem translational stop codons, TAG
and TAA, and annealed at specific positions to obtain the desired polypeptide
length. PCR amplification comprised a total of 30 cycles with an annealing
temperature of 52°C. The amplified DNA products were purified with the
Qiagen PCR purification kit according to the manufacturer’s protocol and
verified on a 1% agarose gel.
In addition, the hydrophobic regions from 2B were introduced into the mod-
ified Lep sequence from the pGEM1 plasmid (24, 34) between the SpeI and
KpnI sites using two double-stranded oligonucleotides with overlapping over-
hangs at the ends. The complementary oligonucleotide pairs first were annealed
at 85°C for 10 min and then slowly cooled to 30°C, after which the two annealed
double-stranded oligonucleotides were mixed, incubated at 65°C for 5 min,
cooled slowly to room temperature, and ligated into the vector. The replace-
ments of Lys 46 by Gly, Glu, Gln, and Arg in the LepHR1 construct were done
using the QuikChange mutagenesis kit from Stratagene (La Jolla, CA) according
to the manufacturer’s protocol. All DNA manipulations were confirmed by the
sequencing of plasmid DNAs.
Expression in vitro. Full-length 2B DNA was amplified from 2B/P2 plasmid
using a reverse primer with a stop codon at the end of the 2B sequence (2B-
derived expressions), or the DNA derived from the pGEM1 plasmid was tran-
scribed directly (2B/P2 construct). Alternatively, viroporin 2B was amplified
fused to the first 50 amino acids from P2 using a reverse primer with tandem stop
codons at the 3 end (2B/50P2). The transcription of the DNA derived from the
pGEM1 plasmid was done as described previously (61). Briefly, the transcription
mixture was incubated at 37°C for 2 h. The mRNA products were purified with
a Qiagen RNeasy clean-up kit and verified on a 1% agarose gel.
In vitro translation of in vitro-transcribed mRNA was performed in the pres-
ence of reticulocyte lysate, [35S]Met/Cys, and dog pancreas microsomes as de-
scribed previously (21, 61). Lep constructs with HR-tested segments were tran-
scribed and translated as previously reported (33, 34). For the posttranslational
membrane insertion experiments, 2B-derived mRNAs were translated (37°C for
1 h) in the absence of rough microsomal membranes (RMs). Translation then
was inhibited with cycloheximide (10 min at 26°C; 2 mg/ml final concentration),
after which RMs were added and incubated for an additional hour at 37°C. In all
cases, after translation membranes were collected by ultracentrifugation and
analyzed by sodium-dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Finally, the gels were visualized on a Fuji FLA3000 phosphorimager
with ImageGauge software.
For EndoH treatment, the translation mixture was diluted in 4 volumes of 70
mM sodium citrate (pH 5.6) and centrifuged (100,000 g for 20 min at 4°C). The
pellet was resuspended in 50 l of sodium citrate buffer with 0.5% SDS and 1%
-mercaptoethanol, boiled for 5 min, and incubated for 1 h at 37°C with 0.1 mU
of EndoH. The samples were analyzed by SDS-PAGE.
For the proteinase K protection assay, the translation mixture was supple-
mented with 1 l of 50 mM CaCl2 and 1 l of proteinase K (4 mg/ml) and then
digested for 40 min on ice. The reaction was stopped by adding 1 mM phenyl-
methylsulfonyl fluoride (PMSF) before SDS-PAGE analysis.
FIG. 1. Membrane association of the chimeric viroporin 2B/P2 pro-
tein. At the top is a schematic representation of the poliovirus 2B/P2
chimeric protein (the fused P2 domain is shown in gray). Amino acid
residues are shown (HR1 and HR2 are highlighted in gray boxes). The
gel in the middle shows the segregation of [35S]Met/Cys-labeled viro-
porin 2B/P2 fusion protein into membranous and soluble fractions
(untreated) and after alkaline wash (Alk. Ext.; sodium carbonate buf-
fer) or urea treatments. P and S denote pellet and supernatant, re-
spectively. In the graph at the bottom, to calculate the percentages of
protein the signals present in each pellet and supernatant pair were
summed and set to 100%. Data correspond to averages from at least
three independent experiments; error bars show standard deviations.
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Membrane sedimentation, alkaline wash, and urea treatments. The transla-
tion mixture was diluted in 8 volumes of buffer A (35 mM Tris-HCl at pH 7.4 and
140 mM NaCl) for the membrane sedimentation, 4 volumes of buffer A supple-
mented with 100 mM Na2CO3 (pH 11.5) for the alkaline wash, and 4 or 8 M urea
for urea treatments. The samples were incubated on ice for 30 min and clarified
by centrifugation (10,000  g for 20 min). Membranes were collected by the
ultracentrifugation (100,000 g for 20 min at 4°C) of the supernatant onto 50-l
sucrose cushions. Pellets (P) and supernatants (S) of the ultracentrifugation were
analyzed by SDS-PAGE.
Phase separation in Triton X-114 solution. The phase separation of integral
membrane proteins using the detergent Triton X-114 was performed as de-
scribed previously (10, 41). Triton X-114 (1%, vol/vol) was added to a translation
mixture that previously had been diluted with 180 l of phosphate-buffered
saline (PBS). After mixing, the samples were incubated at 0°C for 1 h and
overlaid onto 300 l of PBS supplemented with 6% (wt/vol) sucrose and 1%
(vol/vol) Triton X-114. After 10 min at 30°C, an organic droplet was obtained by
centrifugation for 3 min at 1,500  g. The resulting aqueous upper phase (AP;
200 l) was collected, and the organic droplet at the bottom of the tube was
diluted with PBS (organic phase [OP]). Both OP and AP were supplemented
with sample buffer and boiled for 10 min prior to 12% (Fig. 2B) or 20% (Fig. 2C)
SDS-PAGE analysis.
Transfection assay. Baby hamster kidney (BHK) cells that stably express the
T7 RNA polymerase (clone BSR-T7/5), designated BHKT7 (11), were used.
Cells were grown at 37°C in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 5 or 10% fetal calf serum (FCS) and nonessential amino
acids. BHKT7 cells additionally were treated with Geneticin G418 (Sigma) on
every third passage at a final concentration of 2 mg/ml. Cells were transfected
with 1 g of plasmid pTM1-2B (3, 4) or the different constructs plus 2 l of
Lipofectamine per well in Opti-mem medium (Invitrogen) for 2 h at 37°C. After
2 h, Lipofectamine was removed and the cells were supplemented with fresh
medium containing 5% FCS.
RESULTS
Viroporin 2B is an integral membrane protein. Viroporin
2B amino acid sequence (Fig. 1) has been parsed to test the
performance of several commonly used algorithms for predict-
ing the topology of integral membrane proteins. As shown in
Table 1, the predicted outcome showed great variability ac-
cording to the methods used, likely due to the limited hydro-
phobicity of the membrane-associating regions of 2B. The
membrane association properties of the full-length viroporin
2B were studied using an in vitro system that closely mimics the
in vivo situation, in which cytosolic and membrane fractions of
in vitro-translated [35S]Met/Cys-labeled 2B/P2 fusions in the
presence of ER-derived microsomes were collected and ana-
lyzed by SDS-PAGE and autoradiography. In this system, the
microsomes provide all of the membrane insertion and glyco-
sylation components (i.e., the translocon machinery and the
oligosaccharyltransferase enzyme). The reporter P2 domain is
the extramembrane C-terminal domain from the bacterial
leader peptidase (Lep) that carries an N-glycosylation site ex-
tensively used to report membrane translocation (Fig. 1, top).
The viroporin 2B/P2 chimera was recovered mainly from the
100,000  g pellet fraction (Fig. 1, untreated lanes) after the
centrifugation of the microsome-containing translation reac-
tion mixture, indicating that it could be either a membrane-
associated protein or a lumenally translocated protein. The
absence of glycosylation suggested that the chimeric protein
was not translocated into the lumen of the microsomes. Nev-
ertheless, to differentiate between these possibilities the trans-
lation reaction mixtures were washed with sodium carbonate
(pH 11.5), which renders microsomes into membranous sheets,
releasing the soluble luminal proteins (35, 41). As shown in
Fig. 1, the 2B/P2 fusion appeared to be preferentially associ-
FIG. 2. Triton X-114 partition of viroporin 2B and 2B-derived pro-
teins. (A) Structural organization of the proteins used in the Triton
X-114 partition experiments. (B) SDS-PAGE (12% polyacrylamide)
analysis after Triton X-114 treatment of 2B/P2 (38 kDa) and 2B/
50P2 (16 kDa) proteins. Integral membrane protein Lep (37 kDa;
the nonglycosylated form) and peripheral PNRSV movement protein
(32 kDa) were processed in parallel as control samples. (C) Phase
separation of viroporin 2B. As a control for small integral membrane
protein, Turnip crinkle virus p9 movement protein (9 kDa) was
included. The gels used contained 20% polyacrylamide. AP and OP
refer to aqueous and organic phases, respectively.
TABLE 1. Computer analysis of viroporin 2B amino acid sequence
Algorithm Membraneprotein
No. of TM segments
(starting aa/ending aa)
DAS Yes 2 (45/53–64/71)
PHDhtm Yes 2 (41/57–64/72)
MEMSAT3 Yes 1 (44/63)
MEMSAT-SVM Yes 1 (40/55)
SOSUI No 0
TMHMM No 0
TMPred Yes 1 (58/78)
G Prediction Server Yes 1 (61/82)
SPOCTOPUS Yes 1 (48/73)
TopPRED Yes 1 (38/58)
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ated (approximately 58%; lanes 3 and 4) with the membranous
pellet fraction, suggesting a tight association with membranes.
Further treatment with 4 M urea demonstrated that approxi-
mately 88% of the protein was in the supernatant fraction (Fig.
1, lanes 5 and 6). More than 93% of the protein was extracted
from the supernatant fraction by 8 M urea (Fig. 1, lanes 7 and
8), suggesting that 2B/P2 is released from the membrane en-
vironment when the secondary and tertiary structures of the
protein are lost.
The translation reaction mixtures also were treated with
Triton X-114, a nonionic detergent that forms a separate or-
ganic phase into which membrane lipids and hydrophobic pro-
teins are segregated from the aqueous phase, which contains
nonintegral membrane proteins (10, 35). The 2B/P2 fusion
protein (Fig. 2A) was detected in both the aqueous and organic
phases (Fig. 2B, lanes 5 and 6), while a reduction of the P2
domain to its 50 N-terminal residues (Fig. 2A) led to the
organic-phase detection of the chimera (Fig. 2B, lanes 7 and
8). Control analyses of Lep and Prune necrotic ring-spot virus
(PNRSV) p32 movement protein showed, as previously dem-
onstrated (35), organic- and aqueous-phase detections, respec-
tively. Finally, viroporin 2B translated in the absence of fused
domains was detected only in the organic phase (Fig. 2C, lanes
1 and 2), indicating that viroporin 2B is an integral membrane
protein.
Insertion of the viroporin 2B hydrophobic regions into bio-
logical membranes. We assayed the membrane insertion ca-
pacities of the viroporin 2B hydrophobic regions using an in
vitro experimental system (24), which accurately reports the
integration of transmembrane (TM) helices into microsomal
membranes. This system uses ER-derived microsomal mem-
branes and provides a sensitive way to detect the insertion or
translocation of hydrophobic regions through the Sec translo-
con (25). An obvious advantage of this system is that the
insertion assays are performed in the context of a biological
membrane. The system is based on the cotranslational glyco-
sylation performed by the oligosaccharyltransferase (OST) en-
zyme. OST adds sugar residues to an NX(S/T) consensus se-
quence (53), with X being any amino acid except proline (52),
after the protein emerges from the translocon channel. The
glycosylation of a protein region translated in vitro in the pres-
ence of microsomal membranes therefore indicates the expo-
sure of this region to the OST active site on the luminal side of
the ER membrane. In our first experimental assay (Fig. 3), a
segment to be assayed (HR tested) is engineered into the
luminal P2 domain of the integral membrane protein Lep from
E. coli, where it is flanked by two acceptor sites (G1 and G2)
for N-linked glycosylation (Fig. 3A). Both engineered glycosy-
lation sites are to be used as membrane insertion reporters.
The rationale behind using two glycosylation sites is that G1
will always be glycosylated due to its native luminal localiza-
tion, while G2 will be glycosylated only on the translocation of
the tested TM region through the microsomal membrane.
Thus, single glycosylation indicates a correct TM integration
(Fig. 3A, left), whereas double glycosylation reports the non-
integration capability of the tested HR segment (Fig. 3A,
right). The single glycosylation of the molecule results in an
increase in molecular mass of about 2.5 kDa relative to the
observed molecular mass of Lep expressed in the absence of
microsomes, and the mass is around 5 kDa in the case of
double glycosylation.
The translation of the chimeric constructs harboring the
predicted viroporin 2B hydrophobic regions as HR-tested seg-
ments resulted mainly in double-glycosylated forms (Fig. 3B,
FIG. 3. Insertion of viroporin 2B hydrophobic regions 1 (HR1) and
2 (HR2) into microsomal membranes using Lep as a model protein.
(A) Schematic representation of the leader peptidase (Lep) construct
used to report insertion into the ER membrane of 2B HR1 and HR2.
The HR under study is inserted into the P2 domain of Lep flanked by
two artificial glycosylation acceptor sites (G1 and G2). The recognition
of the HR by the translocon machinery as a TM domain locates only
G1 in the luminal side of the ER membrane, preventing G2 glycosy-
lation. The Lep chimera will be doubly glycosylated when the HR
being tested is translocated into the lumen of the microsomes. (B) In
vitro translation in the presence of membranes of the different Lep
constructs. Constructs containing HR1 (residues 35 to 55; lanes 1 and
2) and HR2 (residues 61 to 81; lanes 3 and 4) were transcribed and
translated in the presence of membranes. Control HRs were used to
verify sequence translocation (trans.; lanes 5 and 6) and membrane
integration (inser.; lanes 7 and 8). Bands of nonglycosylated protein
are indicated by a white dot; singly and doubly glycosylated proteins
are indicated by one and two black dots, respectively. (C) The HR
sequence in each construct is shown together with the predicted G
apparent value, which was estimated using the G prediction algo-
rithm available on the Internet (http://dgpred.cbr.su.se/). Lysine resi-
dues in HR1 are shown in boldface. (D) In vitro translation of HR1-
derived mutants at lysine 46.
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lanes 2 and 4), which is consistent with the translocation of
these regions into the lumen of the ER. Control constructs
with previously tested (37) translocation and integration se-
quences are shown in lanes 6 and 8, and they disclose the
expected double and single glycosylation patterns, respectively
(Fig. 3B). The permeabilization induced by an overlapping
peptide library that spanned the complete viroporin 2B se-
quence mapped the cell plasma membrane-porating activity to
the partially amphipathic HR1 domain (32). This region con-
tains three lysine residues that would preclude TM disposition
(Fig. 3C), especially in the case of lysine 46, since it would be
located roughly in the center of the hydrophobic core of the
lipid bilayer. Nevertheless, the replacement of this residue by
glycine, glutamic acid, glutamine, or arginine renders glycosy-
lation patterns consistent with the translocation of the hydro-
phobic region into the ER lumen (Fig. 3D). Taken together,
these results suggest that an isolated HR1 segment does not
span ER-derived membranes in an Nlum/Ccyt orientation.
Since native 2B does not have a cleavable signal sequence, it
seems likely that HR1 acts as a signal-anchor sequence having
an Ncyt/Clum orientation in the membrane (36). To test HR1
insertion in a reverse orientation, another Lep construct (Lep)
was used. In this Lep construct, HR1 replaces the second TM
segment (H2) from Lep (Fig. 4A). The glycosylation acceptor
site (G2) located in the beginning of the P2 domain will be
modified only if the HR1 segment inserts into the membrane,
while the G1 site, embedded in an extended N-terminal se-
quence of 24 amino acid residues, is always glycosylated. We
found that HR1 significantly inserts into the membrane (up to
60% of the molecules) with the appropriate topology (Fig. 4B).
The nature of the cytosolic/luminal domains was further exam-
ined by proteinase K (PK) digestions. Treatment with PK de-
grades domains of membrane proteins that protrude into the
cytosol, but membrane-embedded or luminally exposed do-
mains are protected. The addition of PK to a LepHR1 trans-
lation mixture (Fig. 4B, lane 4) rendered a protected, glycosyl-
ated HR1-P2 fragment, suggesting the proper insertion of
HR1 sequence with an Ncyt/Clum orientation.
Viroporin 2B integrates into the ER membrane through the
translocon with an N-terminal/C-terminal cytoplasmic orien-
tation. The microsomal in vitro system closely mimics the con-
ditions of in vivo membrane protein assembly into the ER
membrane. HR1 is properly recognized by the translocon as a
TM segment out of its native context (Fig. 4). However, the
presence of fused domains can influence its membrane inser-
tion capacity. Hence, we next sought to investigate whether
HR1 also could direct the integration into the ER membrane
of the native 2B sequence (i.e., in the absence of nonviral fused
domains) through the translocon.
Because N-glycosylation acceptor sites are absent from the
viroporin 2B sequence, several modifications were prepared to
determine the TM disposition of different 2B-derived proteins.
First, to gain topological information, an N-glycosylation ac-
ceptor site was engineered at the hydrophilic N-terminal re-
gion of the 2B sequence by mutating glutamine 20 to an ac-
ceptor asparagine (…20NIS…; construct 2BNtGlyc). Second,
we added a C-terminal N-glycosylation tag (CtGlyc; NST-
MMM [the glycosylation sequon is in boldface]) that has been
proven to be efficiently glycosylated (6). The first 60 residues of
the viroporin 2B carrying an N-terminal glycosylation site were
translated using C-terminal tags (Fig. 5A) either with an N-
glycosylation acceptor site as a C-terminal tag (2BNt/Ct; Fig.
5B, lanes 1, 3, and 5) or with a nonacceptor site (2BNt/CtØ;
Fig. 5B, lanes 2, 4, and 6). The lack of glycosylation at the
N-terminal engineered acceptor site together with the efficient
glycosylation observed only when using the C-terminal accep-
tor site (Fig. 5B, lane 3), as proven after EndoH treatment
(Fig. 5B, lane 5), strongly indicates that HR1 in the viroporin
context is acting as a noncleavable signal sequence and is
properly recognized by the translocon machinery to be inserted
into the membrane with its N terminus facing the cytoplasm
(Ncyt/Clum topology). In addition, by blocking protein synthesis
after 2BNt/Ct has been translated in the absence of mem-
branes, we confirmed that the truncated version of 2B (2BNt/
Ct) needs to be cotranslationally inserted into the ER mem-
brane. As shown in Fig. 5C, 2BNt/Ct was glycosylated when
microsomal membranes were added to the translation mixture
cotranslationally. In contrast, when microsomal membranes
were included posttranslationally (i.e., after translation had
been inhibited by cycloheximide), the C-terminal acceptor site
was not glycosylated (Fig. 5C, lane 3), thereby emphasizing
that truncated 2B is integrated cotranslationally through the
ER translocon.
Because of the low hydrophobicity and the relatively poor
insertion propensity found in the Lep system for HR2 (Fig. 3),
it is predicted that the 2B C-terminal region will be translo-
cated into the ER lumen. However, 2B hydrophobic regions
also are responsible for the membrane anchoring of the 2BC
FIG. 4. Insertion of HR1 into microsomal membranes using the
Lep construct. (A) Schematic representation of the Lep-derived con-
struct (Lep). In this Lep construct (40 kDa; the nonglycosylated
form), HR1 replaces the H2 domain from Lep. The glycosylation
acceptor site (G2) located in the beginning of the P2 domain will be
modified only if HR1 inserts into the membrane, while the G1 site,
embedded in an extended N-terminal sequence of 24 amino acids, is
always glycosylated. (B) In vitro translation in the presence of mem-
branes. Bands of nonglycosylated protein are indicated by a white dot;
singly and doubly glycosylated proteins are indicated by one and two
black dots, respectively. The protected glycosylated HR1/P2 fragment
(36.5 kDa) is indicated by a black triangle.
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precursor, which performs its enzymatic and RNA binding
activities in the cytosolic compartment. Thus, we speculated
that some type of helix-helix interaction stabilizes the insertion
of HR2 to keep an Ncyt/Ccyt 2B topology. It has been shown
recently that in some cases the insertion of poorly hydrophobic
regions depends on the presence of neighboring loops and/or
TM segments (20), especially in the case of the preceding TM
segment (23, 55). In our attempts to unravel the disposition of
2B in biological membranes, we focused on the insertion of
truncated C-terminal reporter tag fusions. In Fig. 6 we show a
series of experiments where HR1 and various lengths of down-
stream sequence were translated as truncated proteins with an
N-glycosylation C-terminal tag (Fig. 6A). A mutant polypep-
tide truncated at the end of the hydrophilic loop between HR1
and HR2 (60-mer) is highly glycosylated (65%; Fig. 6B, lane
2), indicating that, similarly to what is shown in Fig. 5B, the
C-terminal glycosylation tag has been translocated into the
lumen of the ER, and thus HR1 is integrated into the ER
membrane in a Ncyt/Clum orientation in this construct (Fig. 6D,
left). The percentage of glycosylated truncated proteins is re-
ported in Fig. 6C. Extending the 2B sequence to include
roughly half of HR2 has a significant effect on this pattern
(72-mer; Fig. 6B and 6C), suggesting some tendency of these
truncated molecules to insert the C-terminal tag into the mem-
brane. Moreover, extending the 2B sequence four residues
(roughly one helical turn; 76-mer) (Fig. 6C) substantially di-
minished glycosylation (21%). The glycosylation level for the
truncated protein shown in Fig. 6C cannot be explained by an
increased hydrophobicity of the added amino acids, since the
total free energy predicted (Gpred) for the 73CDAS76 se-
quence is 4.31 kcal/mol, where a positive value is indicative of
extramembrane disposition (the calculation of Gpred was car-
ried out using the scale of Hessa and collaborators [24]). In-
terestingly, the addition of four leucine residues (Gpred 	

2.2 kcal/mol) instead of the 73CDAS76 sequence [76-
mer(L4)] strongly precludes glycosylation (3%) (Fig. 6C),
demonstrating the clear hydrophobic effect of the leucine res-
idues in this construct. This was further corroborated by ex-
tending the protein to include up to eight leucine residues
FIG. 5. Membrane insertion of 60-mer viroporin 2B. (A) Structural
organization of the 2B 60-mer truncated construct. (B) In vitro trans-
lations were performed in the presence () or in the absence of
C-terminal glycosylation tag, RMs, and EndoH as indicated. (C) The
2BNt/Ct construct was translated in either the absence (lanes 1 and 3)
or the presence (lane 2) of RMs. Lane 2, cotranslationally added
microsomes. Lane 3, RMs were added posttranslationally (after 1 h of
translation and 10 min of cycloheximide treatment; Post-), and incu-
bation was continued for another 1 h.
FIG. 6. Effect of HR2 on 2B 60-mer insertion and topology.
(A) Structural organization of full-length and truncated viroporin 2B
constructs. (B) In vitro translation of truncated viroporin 2B 60-mer,
72-mer, 80-mer, and full-length (2B/CtGlyc) constructs in which a
fused C-terminal N-glycosylation tag (rectangle) provides a simple
readout for topology determination. The presence of RMs and nong-
lycosylated and glycosylated proteins (empty and black dots, respec-
tively) is indicated. (C) In vitro glycosylation of truncated viroporin
2B-derived proteins. The level of glycosylation is quantified from SDS-
PAGE gels by measuring the fraction of glycosylated (fg) versus gly-
cosylated-plus-nonglycosylated (fng) molecules, using the equation p 	
fg/fg  fng. Data correspond to averages from at least four independent
experiments, and error bars show standard deviations. (D) Topological
models for 2B constructs. Nt, N terminus.
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[80-mer(L8)] (Fig. 6C). Finally, both the mutant truncated at
the end of HR2 (80-mer) and the 2B full-length construct
(2B/CtGlyc) had little effect on this pattern (17 and 10%
glycosylation, respectively), indicating that the C terminus of
the majority of these tagged proteins is cytosolic, and thus the
HR2 sequence included in these constructs is integrated into
the membrane in an Nlum/Ccyt orientation (Fig. 6D, right).
To confirm that the same topology is adopted by the
full-length 2B protein, several 2B-derived constructs were
prepared and their membrane disposition experimentally
determined. The translation of the C-terminal-tagged 2B
protein (2B/CtGlyc) (Fig. 7A) in the presence of RMs re-
sulted in glycosylation in 8% of the molecules, as demon-
strated by EndoH (a glycan-removing enzyme) treatment
(Fig. 7B, lanes 1 to 3). The addition of the first 50 residues
of the Lep P2 domain (2B/50P2) (Fig. 7A), which contains
an N-glycosylation acceptor site as a topological reporter,
yielded glycosylation in 5% of the viroporin 2B-derived
molecules (Fig. 7B, lanes 4 to 6). Furthermore, when full-
length Lep P2 domain was used as a reporter domain, the
chimera was not glycosylated at all (2B/P2) (Fig. 7B, lanes 7
to 9). Finally, the in vitro translation of a construct harbor-
ing an N-terminal glycosylation acceptor site (2BNtGlyc,
Fig. 7A) in the presence of RM only resulted in unmodified
molecules (Fig. 7B, lanes 10 to 12). Taken together, these
results suggest a preferential N-/C-terminal cytoplasmic ori-
entation for viroporin 2B when expressed in the presence of
ER-derived microsomal membranes.
Viroporin 2B topology in mammalian cells. To further as-
sess the topology adopted by functional viroporin 2B in
membranes, 2B variants containing designed N-glycosyla-
tion sites at different positions were expressed in cultured
cells, and their plasma membrane-permeabilizing capacities
were assessed (Fig. 8). For this purpose, the 2B variants
were cloned in pTM1 vector and transfected in BHK cells
that stably express the T7 RNA polymerase. These cells
posses the machinery required for synthesizing the virion
components and even to assemble infectious particles. As
expected, 2B expression permeabilized BHK cells to the
antibiotic hygromycin B (31) (Fig. 8B, lane 4). Although the
synthesis of unmodified 2B is not detectable by radioactive
labeling in the permeabilized cells (Fig. 8B, top), it can be
detected by Western blotting using a specific 2B antibody
(Fig. 8B, bottom). No glycosylation of 2B was observed
when this protein bears the N-glycosylation site at the amino
terminus, in the turn, or at the carboxy terminus of this
viroporin (Fig. 8B, lanes 5 to 8). In addition, these two
viroporin 2B variants retain their capacity to permeabilize
cells to hygromycin B, suggesting that they are located at the
membrane and exhibit the ability to alter membrane perme-
ability. It should be noted that in the case of the N-glyco-
sylation site located at the turn, although the location is luminal
the absence of glycosylation is due to its proximity to the TM
domains as previously reported (42, 44). In conclusion, the in
vitro and in vivo assays consistently indicate that both the N and
FIG. 7. Insertion and topology of full-length viroporin 2B protein.
(A) The structural organization of the 2B-derived constructs is shown
at the top. The N-glycosylation site is highlighted by a Y-shaped sym-
bol both when inserted in the protein sequence and when added as a
C-terminal reporter tag (rectangles). (B) In vitro translation was per-
formed in the presence () and in the absence (
) of RMs and
EndoH as indicated. Nonglycosylated and singly glycosylated proteins
are indicated by empty and black dots, respectively.
FIG. 8. Permeabilization activity of 2B-derived constructs in
BHKT7 cells. (A) Structural organization of the transfected 2B vari-
ants. (B) BHKT7 cells were transfected with pTM1-2Bwt or with
pTM1-2B variants. At 3 h posttransfection, cells were pretreated
with hygromycin B (HB) at 0.5 mM for 15 min and then labeled with
[35S]Met/Cys for 45 min in the presence of the inhibitor. After
labeling, the proteins were analyzed by SDS-PAGE (17.5%) fol-
lowed by fluorography and autoradiography (top). The synthesis of
2B protein was detected by Western blotting using specific rabbit
polyclonal antibodies (bottom). The numbers below each lane rep-
resent the percentage of protein synthesis in the presence of hygro-
mycin B as calculated by densitometric scanning.
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C termini of viroporin 2B face the cytoplasm, as displayed in
Fig. 9A.
DISCUSSION
Viroporins are a group of proteins responsible for altera-
tions in the permeability of cellular membranes during virus
infection, favoring the release of viral particles from infected
cells (reviewed in reference 22). The molecular mechanisms by
which viroporins insert into cell membranes remain largely
unknown. In this study, we demonstrate that poliovirus viro-
porin 2B is a double-spanning integral membrane protein that
can be inserted into the ER membrane through the translocon
machinery.
Computer-assisted membrane protein topology prediction is
a useful starting point for experimental studies of membrane
proteins. We have used 10 popular prediction methods and
found large discrepancies between their predictions. Two of
the algorithms failed to predict 2B as an integral membrane
protein, and two of them assigned two TM segments for the
protein. It should be noted that the reliability of a topology
prediction can be estimated by the number of prediction meth-
ods that agree. Since six of the algorithms predicted 2B as a
membrane protein with only one TM segment, these results
clearly highlight that the presence of helical hairpin structures,
which was not detected even by the methods predicting reen-
trant loops (MEMSAT-SVM and SPOCTOPUS), may be
missed by current predictive methods, as previously suggested
for a different TM helical hairpin (40).
The membrane association of 2B/P2 fusion protein was re-
sistant to alkaline extraction. Since this treatment disrupts mi-
crosomal membranes and releases any soluble luminal protein,
this result indicates that the fusion protein is not translocated
to the lumen of the microsomes. Urea treatments solubilized
our fusion protein (Fig. 1), indicating that secondary and ter-
tiary structures in 2B play an important role in 2B insertion.
The latter results contrast with previous work that showed that
coxsackievirus 2B/enhanced green fluorescent protein fusions
were resistant to urea extraction (18). This discrepancy could
be derived either from the differences found in the amino acid
sequence of both 2B proteins or from the use of different
fusion proteins in both cases. In fact, a significant influence of
the P2 domain can be observed in our Triton X-114 partition
experiments. Fusions containing the full P2 domain partition
significantly into the aqueous phase, whereas the addition of
the 50 N-terminal residues from this domain promoted the
partitioning of the shorter chimera into the organic phase.
These results clearly demonstrated integral membrane protein
behavior (compare lanes 5 and 6 with lanes 7 and 8 in Fig. 2B),
as corroborated by partition experiments using full-length 2B
(Fig. 2C, lanes 1 and 2).
By challenging the hydrophobic regions of 2B in a model
protein construct (Lep), we demonstrate first that these re-
gions do not integrate as TM segments in the presence of
ER-derived membranes when expressed separately (Fig. 3). It
should be mentioned that, in these Lep-derived constructs, the
HR1 segment is forced to insert into the membrane with an
Nlum/Ccyt topology, and this topological effect can prevent the
proper TM disposition of this region. In fact, using a Lep-
derived variant (Lep), we demonstrated the TM disposition of
HR1 when expressed with an Ncyt/Clum orientation (Fig. 4).
The glycosylation data obtained in the context of the parental
2B sequence using engineered and truncated proteins provided
compelling evidence that HR1-HR2 also may integrate
cotranslationally into the membrane in the absence of fused
domains. Hence, a truncated 2B protein containing HR1 in-
serted efficiently into ER microsomal membranes adopting an
Ncyt/Clum topology (Fig. 5), and the addition of HR2 residues
to this construct resulted in the cytoplasmic reorientation of
the C terminus (Fig. 6). Furthermore, the lack of glycosylation
at N-glycosylation acceptor sites engineered at different posi-
tions, both in an in vitro microsomal system (Fig. 7) and in
cultured cells (Fig. 8), suggests that both the N and C termini
of viroporin 2B protein reside on the cytosolic side of the
membrane. In the context of the P2 polyprotein, the mem-
brane topology found in the present work leaves the protease
cleavage sites of P2 facing the cytosol, which is suitable for
polypeptide processing by viral proteases.
Taken together, these data support the capacity of the HR
domains to act as interacting TM segments in their natural
contexts. In this sense, we have described previously the inte-
gration into the ER membrane of two closely spaced mem-
brane-spanning segments of viral origin, where both TM seg-
ments of the nascent protein bind to one or more translocon
proteins and are held until the termination of translation,
whereupon they are released laterally as a helical hairpin into
the lipid phase (50, 51). More recently, this mechanism of
partition into the membrane as a pair of helices has been
observed by others using a nonviral membrane protein (13).
Thus, the retention of a first cationic amphipathic segment
(HR1) at the ER translocon to generate a helical hairpin might
facilitate partitioning into the lipid phase by shielding the polar
amino acids that could compromise effective membrane inte-
gration (36).
These findings provide important new insights into the mo-
lecular architecture and the molecular mechanism of 2B inte-
gration into the membrane. The synergic effect found for pore
formation between HR1 and HR2 in a previous peptide-based
FIG. 9. (A) Topological model for 2B association with membranes.
(B) Turn-inducing propensity at the interhelical region of the viroporin
2B helical hairpin according to the scale of Monne´ and coworkers (39).
The five amino acid residues interconnecting HR1 and HR2 are shown
flanked by the putative last two residues from the HR1 helix and the
putative first two residues from HR2. All residues connecting HR1 and
HR2 are turn inducers (normalized turn potential, 1). The residues
are highlighted according to their turn potential: black for a potential
lower than 1 (Ile54), dark gray for a potential between 1 and 2 (Thr55,
Tyr58, and Thr61), and light gray for a potential above 2 (Arg56,
Asn57, Glu59, and Asp60).
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analysis, which indicated that both HRs cooperate in mem-
brane permeabilization (48), suggests that HR1 and HR2 in-
teract with each other to form a helix-turn-helix (helical hair-
pin) motif that traverses the lipid bilayer. An additional source
of stability of this motif can be the turn between the two
helices. It has been shown that charged and polar residues
(plus prolines and glycines) display turn induction in a TM
polyleucine stretch (38); in our case, we do not know exactly
which amino acid residues form the turn in the membrane-
bound viroporin, although in all likelihood the turn occurs
between the highly hydrophilic residues 55 and 61. Figure 9B
shows this region of viroporin 2B, where the residues are
highlighted according to their turn-inducing propensities (38).
All residues present in this region are strongly turn inducing
(normalized turn potential, 1). Among them, four (Arg56,
Asn57, Glu59, and Asp60) have a high turn potential (2). In
essence, a great concentration of turn-promoting residues is
found in the region connecting HR1 and HR2. Thus, in the
membrane-bound form, we can expect the turn of viroporin 2B
to be centered on 56RNYED60. Interestingly, previous mu-
tagenesis studies using the CBV 2B protein showed that the
negatively charged residues found in this short hydrophilic turn
between HR1 and HR2 are indeed important for the mem-
brane-active character of 2B protein (16). Moreover, recent
molecular dynamic simulations of the poliovirus 2B channel/
pore-forming regions suggested that Glu59 and Asp60 are in-
volved in the helical hairpin formation (45). In any case, it
seems clear that the turn may play a significant role in the
stability and integration of the membrane-bound 2B protein.
In addition, the topology observed in the present work agrees
with previous data obtained with different fusion proteins (18).
Furthermore, the localization of the C terminus at the cytosolic
side of the membrane is consistent with the need for the pro-
teolytic liberation of the 2B protein from the precursor 2BC
polyprotein by a cytosolic viral protease cleavage, which is
accomplished by 3Cpro (54). This could occur after the mem-
brane insertion of 2BC or even the entire P2 precursor
(2ABC).
Our findings further suggest a physiological role for translo-
con-mediated 2B integration into the ER membrane. Our
combined analysis predicts a marginal propensity for 2B poly-
peptide to insert into membranes (Table 1 and Fig. 3D). On
the other hand, upon viral entry, initially synthesized 2B or
2BC proteins will remain diluted in the cytosol of the infected
cell. Marginal hydrophobicity together with low concentration
are predicted to reduce the probability of the spontaneous
insertion of 2B and 2BC into their primary target organelle:
the Golgi complex (18, 49). Thus, we speculate that cotransla-
tional insertion into the ER membrane is a particularly rele-
vant phenomenon at the initial stages of the infectious cycle,
during which both the viral mRNA levels and the concentra-
tion of the translated viral proteins are predictably low. Under
those conditions, the cellular protein biosynthesis and vesicular
transport machineries remain functional, and 2B and its 2BC
precursor likely are synthesized as additional cell membrane
proteins. From the ER, these proteins may reach the Golgi
compartment membrane to fulfill regulatory and/or signaling
functions that result in the disruption of Ca2 homeostasis (5,
15) and vesicular transport inhibition (7, 15). At later stages,
the canonical ER-Golgi protein-trafficking pathway no longer
is functional and/or required for viral replication. The massive
proliferation of cell endomembranes (viroplasm) and the high
levels of viral protein synthesis result in higher effective con-
centrations of these components inside the infected cell sys-
tem. Under those conditions, it is predicted that the sponta-
neous insertion into the membrane of a significant amount of
synthesized 2B and 2BC will ensue.
In summary, viroporin 2B may use common structural ar-
rangements to integrate into the ER membrane through the
translocon, at least during the initial stages of the viral repli-
cative cycle. The development of in vitro assays designed to
dissect the membrane integration process will lead to a better
understanding of the membrane permeabilization mechanisms
that act during enterovirus infection.
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